Yongning Jia
Yongning Jia publishes mostly in Pulmonary and Respiratory Medicine, Surgery and Oncology, on topics such as Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment and Gastrointestinal Tumor Research and Treatment.
- World rank
- #1,962,262 of 7,710,434 ranked researchers
- Rank in China
- #301,337 of 978,568
- Works
- 83
- Citations
- 1.4k
- Citations per work
- 17.2
What does Yongning Jia research?
Yongning Jia's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5161.8%
- Medicine5161.8%
- Everything else2124.7%
- Life Sciences1113.5%
- 1Pulmonary and Respiratory Medicine25% of their works
- 2Surgery18% of their works
- 3Oncology10% of their works
- 4Molecular Biology10% of their works
- 5Gastroenterology8% of their works
- 6Cancer Research3% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Esophageal Cancer Research and Treatment
- Gastrointestinal Tumor Research and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cancer Genomics and Diagnostics
- Genetic factors in colorectal cancer
- Military Technology and Strategies
- Colorectal Cancer Surgical Treatments
Which keywords describe Yongning Jia's research?
The keywords of their largest research topics: Endoscopic Resection, Molecular Characterization, Clinical Practice Guidelines, Chemotherapy, Gastric Cancer, Epidemiology, Neoadjuvant Therapy and Preoperative Chemoradiotherapy.
- Modernization
- Air Force
- Microsatellite Instability
- Cancer Genomics
- Biliary Tract Cancer
- Sunitinib
- Esophageal Carcinoma
- Surgical Management
- Preoperative Chemoradiotherapy
- Epidemiology
- Chemotherapy
- Molecular Characterization
- Endoscopic Resection
- Clinical Practice Guidelines
- Gastric Cancer
- Neoadjuvant Therapy
- Prognostic Factors
- Barrett's Esophagus
- Imatinib Mesylate
- Adjuvant Chemotherapy
- Cholangiocarcinoma
- Hereditary Syndromes
- Mutational Signatures
- Laparoscopic Surgery
- Rectal Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 25 words, with their numbers
- Endoscopic Resection702 topics
- Molecular Characterization552 topics
- Clinical Practice Guidelines542 topics
- Chemotherapy501 topic
- Gastric Cancer501 topic
- Epidemiology262 topics
- Neoadjuvant Therapy242 topics
- Preoperative Chemoradiotherapy242 topics
- Prognostic Factors242 topics
- Surgical Management242 topics
- Barrett's Esophagus201 topic
- Esophageal Carcinoma201 topic
- Imatinib Mesylate181 topic
- Sunitinib181 topic
- Adjuvant Chemotherapy92 topics
- Biliary Tract Cancer61 topic
- Cholangiocarcinoma61 topic
- Cancer Genomics51 topic
- Hereditary Syndromes51 topic
- Microsatellite Instability51 topic
- Mutational Signatures51 topic
- Air Force41 topic
- Laparoscopic Surgery41 topic
- Modernization41 topic
- Rectal Cancer41 topic
Where does Yongning Jia work?
Yongning Jia's main affiliation in the publication record is Peking University, China.
How many publications and citations does Yongning Jia have?
OpenAlex counts 83 works and 1,431 citations for Yongning Jia, an h-index of 21, ranking #1,962,262 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yongning Jia. Posts are plain text and can be reported.